JOINT FILING AGREEMENTJoint Filing Agreement • November 3rd, 2023 • Biotechnology Value Fund L P • Investment advice
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated November 3, 2023 (including amendments thereto) with respect to the Common Shares, no par value, of Repare Therapeutics Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
